$4.97 Billion is the total value of PFM Health Sciences, LP's 61 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was 114.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMY | New | BRISTOL MYERS SQUIBB CO | $400,326,000 | – | 7,532,007 | +100.0% | 8.05% | – |
| GOOGL | New | GOOGLE INCcl a | $262,794,000 | – | 234,489 | +100.0% | 5.28% | – |
| A | Buy | AGILENT TECHNOLOGIES INC | $235,817,000 | +27.8% | 4,123,398 | +14.6% | 4.74% | +6.7% |
| AMZN | Buy | AMAZON COM INC | $206,030,000 | +193.0% | 516,639 | +129.7% | 4.14% | +144.5% |
| B108PS | New | ACTAVIS PLC | $199,254,000 | – | 1,186,035 | +100.0% | 4.00% | – |
| MDVN | Buy | MEDIVATION INC | $173,581,000 | +314.2% | 2,719,859 | +289.0% | 3.49% | +245.8% |
| HCA | Buy | HCA HOLDINGS INC | $170,707,000 | +49.6% | 3,578,005 | +34.0% | 3.43% | +24.8% |
| PCP | Buy | PRECISION CASTPARTS CORP | $158,286,000 | +200.2% | 587,767 | +153.3% | 3.18% | +150.6% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $155,708,000 | +26.3% | 2,583,508 | +27.5% | 3.13% | +5.5% |
| VLO | New | VALERO ENERGY CORP NEW | $119,998,000 | – | 2,380,911 | +100.0% | 2.41% | – |
| AMT | Buy | AMERICAN TOWER CORP NEW | $118,537,000 | +35.6% | 1,485,052 | +25.9% | 2.38% | +13.2% |
| TSO | New | TESORO CORP | $117,305,000 | – | 2,005,206 | +100.0% | 2.36% | – |
| FB | New | FACEBOOK INCcl a | $111,338,000 | – | 2,037,334 | +100.0% | 2.24% | – |
| CCI | New | CROWN CASTLE INTL CORP | $103,674,000 | – | 1,411,872 | +100.0% | 2.08% | – |
| CRM | Buy | SALESFORCE COM INC | $97,388,000 | +8.2% | 1,764,597 | +1.8% | 1.96% | -9.7% |
| ENDP | New | ENDO HEALTH SOLUTIONS INC | $79,534,000 | – | 1,178,973 | +100.0% | 1.60% | – |
| HNT | Buy | HEALTH NET INC | $73,517,000 | +123.5% | 2,477,835 | +138.8% | 1.48% | +86.6% |
| CME | New | CME GROUP INC | $71,026,000 | – | 905,252 | +100.0% | 1.43% | – |
| COG | New | CABOT OIL & GAS CORP | $67,737,000 | – | 1,747,597 | +100.0% | 1.36% | – |
| MPC | New | MARATHON PETE CORP | $54,990,000 | – | 599,472 | +100.0% | 1.10% | – |
| MHFI | New | MCGRAW HILL FINL INC | $52,118,000 | – | 666,475 | +100.0% | 1.05% | – |
| AGN | New | ALLERGAN INC | $50,092,000 | – | 450,950 | +100.0% | 1.01% | – |
| Buy | DENDREON CORPnote 2.875% 1/1 | $43,279,000 | +11.2% | 66,969,000 | +10.1% | 0.87% | -7.2% | |
| AUXL | Buy | AUXILIUM PHARMACEUTICALS INC | $40,292,000 | +68.9% | 1,943,672 | +48.3% | 0.81% | +40.9% |
| NFLX | Buy | NETFLIX INC | $39,903,000 | +20.5% | 108,381 | +1.2% | 0.80% | +0.5% |
| THC | Buy | TENET HEALTHCARE CORP | $39,396,000 | +107.6% | 935,335 | +103.0% | 0.79% | +73.3% |
| WDAY | New | WORKDAY INCcl a | $35,325,000 | – | 424,785 | +100.0% | 0.71% | – |
| KYTH | Buy | KYTHERA BIOPHARMACEUTICALS I | $31,069,000 | -11.2% | 831,840 | +8.3% | 0.62% | -25.9% |
| OREX | Buy | OREXIGEN THERAPEUTICS INC | $28,415,000 | +29.4% | 5,047,119 | +40.8% | 0.57% | +7.9% |
| RPRX | Buy | REPROS THERAPEUTICS INC | $28,184,000 | +39.9% | 1,540,091 | +104.9% | 0.57% | +16.9% |
| COO | Buy | COOPER COS INC | $23,672,000 | +93.1% | 191,153 | +102.2% | 0.48% | +61.4% |
| KPTI | New | KARYOPHARM THERAPEUTICS INC | $19,785,000 | – | 889,520 | +100.0% | 0.40% | – |
| MCK | Buy | MCKESSON CORP | $18,903,000 | +34.5% | 117,117 | +6.9% | 0.38% | +12.4% |
| ANAC | New | ANACOR PHARMACEUTICALS INC | $17,703,000 | – | 1,055,014 | +100.0% | 0.36% | – |
| HUM | Buy | HUMANA INC | $13,669,000 | +17.3% | 132,430 | +6.1% | 0.28% | -2.1% |
| New | OREXIGEN THERAPEUTICS INCnote 2.750%12/0 | $12,406,000 | – | 12,635,000 | +100.0% | 0.25% | – | |
| ILMN | New | ILLUMINA INC | $10,404,000 | – | 94,079 | +100.0% | 0.21% | – |
| MYGN | Buy | MYRIAD GENETICS INC | $8,520,000 | +146.0% | 406,103 | +175.6% | 0.17% | +106.0% |
| RLYP | New | RELYPSA INC | $8,038,000 | – | 321,527 | +100.0% | 0.16% | – |
| SCAI | New | SURGICAL CARE AFFILIATES INC | $7,538,000 | – | 216,360 | +100.0% | 0.15% | – |
| OCR | New | OMNICARE INC | $7,450,000 | – | 123,428 | +100.0% | 0.15% | – |
| BLUE | Buy | BLUEBIRD BIO INC | $6,175,000 | +15.7% | 294,326 | +48.7% | 0.12% | -3.9% |
| DNDNQ | New | DENDREON CORP | $6,003,000 | – | 2,007,813 | +100.0% | 0.12% | – |
| BMY | New | BRISTOL MYERS SQUIBB COcall | $2,884,000 | – | 2,045,500 | +100.0% | 0.06% | – |
| MGNX | New | MACROGENICS INC | $2,327,000 | – | 84,846 | +100.0% | 0.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2014-02-21
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MOLINA HEALTHCARE INC | 41 | Q3 2023 | 2.2% |
| HCA HOLDINGS INC | 38 | Q3 2023 | 5.2% |
| HUMANA INC | 37 | Q3 2023 | 3.8% |
| EDWARDS LIFESCIENCES CORP | 36 | Q3 2023 | 3.3% |
| UNITEDHEALTH GROUP INC | 33 | Q3 2023 | 4.8% |
| PENUMBRA INC | 33 | Q3 2023 | 4.8% |
| AERIE PHARMACEUTICALS INC | 28 | Q2 2022 | 3.7% |
| TENET HEALTHCARE CORP | 27 | Q3 2023 | 2.3% |
| ELEVANCE HEALTH INC | 26 | Q3 2023 | 4.2% |
| ICON PLC | 26 | Q3 2023 | 2.5% |
View PFM Health Sciences, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adaptimmune Therapeutics PLC | February 14, 2023 | ? | ? |
| Arcus Biosciences, Inc. | February 14, 2023 | ? | ? |
| Axsome Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Erasca, Inc. | February 14, 2023 | ? | ? |
| Generation Bio Co. | February 14, 2023 | ? | ? |
| IO Biotech, Inc. | February 14, 2023 | ? | ? |
| Jounce Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Outset Medical, Inc. | February 14, 2023 | ? | ? |
| uniQure N.V. | February 14, 2023 | ? | ? |
| AERIE PHARMACEUTICALS INC | February 14, 2022 | ? | ? |
View PFM Health Sciences, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
View PFM Health Sciences, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.